|
June 1, 2007
Cancer Management: A Multidisciplinary Approach, 10th Edition (2007).
Chapter 46
Infectious complications
James Ito, Jr., MD
Infections are among the most common, potentially serious complications of cancer and its treatment. This chapter discusses infections from a syndromic approach: that is, infections present as a complex of signs and symptoms to the clinician. The syndromes addressed include febrile neutropenia, pneumonia, catheter-associated infections, and gastrointestinal infections (Clostridium difficile-associated diarrhea and typhlitis). Special sections focus on fungal and viral infections. INFECTION DURING FEBRILE NEUTROPENIAIt has long been recognized that the incidence of infection is high in patients who develop a fever during neutropenia and that empiric antimicrobial therapy is warranted in such patients. DefinitionsFever is usually defined as a temperature ≥ 38.3°C. Neutropenia is defined as a neutrophil count of 500/µL, although patients with a neutrophil count between 500 and 1,000/µL in whom a decrease is anticipated are considered to be neutropenic. Patients with a neutrophil count EtiologyBacteria Infections occurring during episodes of febrile neutropenia are caused predominantly by aerobic gram-negative bacilli (especially Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) and gram-positive cocci (coagulase-negative staphylococci, β-hemolytic streptococci, viridans streptococci, enterococci, and Staphylococcus aureus). In recent years, gram-positive infections have become more prominent with the increasing use of indwelling IV catheters. Fungi Fungal infections usually occur after a patient has received broad-spectrum antimicrobial therapy and/or steroids. The most common fungal pathogens are Candida species (predominantly C albicans and C tropicalis) and Aspergillus species. Less common are Fusarium, Scedosporium, and Zygomycetes infections (see also section on "Fungal infections"). Viruses Viral infections occurring during neutropenia are caused predominantly by herpesviruses and respiratory viruses. The herpesviruses include herpes simplex virus (HSV), varicella zoster virus (VZV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV). The respiratory viruses include adenovirus, respiratory syncytial virus, parainfluenza virus, influenza A and B viruses, and rhinovirus (see also section on "Viral infections"). Signs and symptomsThe most remarkable aspect of the febrile, neutropenic patient is the lack of physical findings. This is due to the neutropenia and the absence of an inflammatory response at the infection site. The patient may have only a fever with or without chills or rigors. Even if the patient has pneumonia, there may be few respiratory symptoms. Likewise, a perirectal abscess may be relatively asymptomatic. DiagnosisAn initial evaluation and diagnostic work-up of any fever in a neutropenic patient should begin immediately but should not delay the initiation of empiric therapy (see below). A complete history (exposures, past infections, rashes, cough, abdominal pain, diarrhea) should be taken and a physical examination (skin lesions, exit site and tunnel of right atrial catheter, oropharynx, abdomen, perineum) should be performed. Diagnostic work-up should include:
CT If indicated by signs or symptoms, CT scans of the brain (followed by lumbar puncture), chest, abdomen, and pelvis can be performed. Laboratory tests Determination of serum transaminases, CBC, and serum creatinine is also recommended.
Table of Contents
Chapter 1: Principles of Surgical Oncology
Chapter 2: Principles of Radiation Therapy Chapter 3: Principles of Oncologic Pharmacotherapy Chapter 4: Head and Neck Tumors Chapter 5: Thyroid and Parathyroid Cancers Chapter 6: Non–Small-Cell Lung Cancer Chapter 7: SCLC, Mesothelioma, Thymoma Chapter 8: Breast Cancer Overview Chapter 9: Stages 0 and I Breast Cancer Chapter 10: Stage II Breast Cancer Chapter 11: Stage III Breast Cancer Chapter 12: Esophageal Cancer Chapter 13: Gastric Cancer Chapter 14: Pancreatic, Neuroendocrine GI, and Adrenal Cancers Chapter 15: Liver, Gall Bladder, and Biliary Tract Cancer Chapter 16: Colon, Rectal, and Anal Cancers Chapter 17: Prostate Cancer Chapter 18: Testicular Cancer Chapter 19: Urothelial and Kidney Cancers Chapter 20: Cervical Cancer Chapter 21: Uterine Corpus Tumors Chapter 22: Ovarian Cancer Chapter 23: Melanoma and Other Skin Cancers Chapter 24: Bone Sarcomas Chapter 25: Soft-tissue Sarcomas Chapter 26: Primary and Metastatic Brain Tumors Chapter 27: AIDS-related Malignancies Chapter 28: Carcinoma of an Unknown Primary Site Chapter 29: Hodgkin's Lymphoma Chapter 30: Non-Hodgkin's Lymphoma Chapter 31: Multiple Myeloma and Other Plasma Cell Dyscrasias Chapter 32: Acute Leukemias Chapter 33: Chronic Myelogenous Leukemia Chapter 34: Chronic Lymphocytic Leukemia Chapter 35: Myelodysplastic Syndromes Chapter 36: Hematopoietic Cell Transplantation Chapter 37: Pain Management Chapter 38: Management of Nausea and Vomiting Chapter 39: Depression, Anxiety, and Delirium Chapter 40: Hematopoietic Growth Factors Chapter 41: Fatigue and Dyspnea Chapter 42: Anorexia and Cachexia Chapter 43: Long-term Venous Access Chapter 44: Prevention and Management of Radiation Toxicity Chapter 45: Oncologic Emergencies Chapter 46: Infectious Complications Chapter 47: Fluid Complications Appendix 1: Performance Scales Appendix 2: Cancer Info on the Internet Appendix 3: Cancer Drugs and Indications Appendix 4: Chemotherapeutic Agents and Their Uses, Dosages, and Toxicites |
|